Resistance to key HIV drug 'concerningly common'
Thursday, January 28, 2016 - 21:11
in Health & Medicine
HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL (University College London) and funded by the Wellcome Trust.